Apollo Care, LLC SEMAGLUTIDE 7.5mg Recall (December 2026)
The recall involves Apollo Care, LLC SEMAGLUTIDE 7.5mg (5mg/mL) with Glycine 7.5 mg (5mg/mL) in a 1.5 mL sterile multi-dose vial, Rx Only, for subcutaneous injection. The issue is the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material. The affected lot is AC-017272, expiring 12/12/2026, distributed nationwide in the United States.
| Brand | Apollo Care, LLC |
|---|---|
| Product | SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03 |
| Reason | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material |
| Severity | moderate |
| Units affected | 250 |
| Distribution | Nationwide within the U.S |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any vials from Lot AC-017272.
- Contact your healthcare provider or pharmacist for disposal, return, or replacement instructions.
- Check the lot number on your vial to confirm if it is part of this recall.
- Follow the manufacturer’s or FDA guidance for returning or disposing of the product.
How to identify the recalled item
| Lot / date codes | Lot: AC-017272, Exp. 12/12/2026. |
|---|---|
| Lot / date codes | Lot: AC-017273, Exp. 12/12/2026. |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.